Compliance Advisory Board Provides Expert Guidance Based on Experience at Pfizer, Merck, Medtronic, GTx, Johnson & Johnson, and the University of Virginia School of Medicine.
Charlottesville, VA, San Francisco, CA, New York, NY and Paris, France (PRWEB) June 17, 2010 -- To support its focus on regulatory compliance in the life sciences, openQ has formed a Compliance Advisory Board. Board members include experienced veterans from some of the industry’s leading companies. Their expert guidance will help openQ continue to provide innovative and industry-leading software and data products to the marketplace.
“Compliance is dynamic and we’re looking to our advisors to help keep us ahead of our customers’ evolving needs,” said Jim Zuffoletti , President and Co-Founder of openQ. “The Board’s wealth of industry experience and commitment to compliance will provide an invaluable perspective to openQ and our customers.”
Regulatory compliance has always been an important part of the life sciences. Now, however, regulations are becoming more complex, enforcement has increased, and penalties are more severe. Compliance has become critical for anyone doing business in this industry.
openQ’s Compliance Advisory Board is extremely well positioned to provide guidance that will help openQ provide products and services that mitigate compliance risks while providing efficient and effective tools to their users. By easing the compliance burden, such as manually maintaining records of interactions with doctors, users of openQ solutions can spend their time focused on their core medical mission.
The members of the Compliance Advisory Board are:
Dr. Jann Balmer, RN PhD - Dr. Balmer was appointed as the first full-time Director for Continuing Medical Education of the University of Virginia School of Medicine in Decem
Copyright©2010 Vocus, Inc.
All rights reserved